CADD-21. PROTEASOME INHIBITION IS A TARGETED THERAPY FOR PTEN-DEFICIENT GLIOBLASTOMAS

One of the most common genetic alterations in glioblastoma (30–40%) occurs in the PTEN (phosphatase and tensin homolog) tumor suppressor gene, where loss of function has been mechanistically linked to increased tumor cell invasion, and to a lack of radio- and chemo-therapy response. To identify new...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Benitez, Jorge, Finlay, Darren, Ma, Jianhui, Koga, Tomoyuki, Vuori, Kristiina, Furnari, Frank
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216841/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1165
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak